Phase 1 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with a solid tumor (confirmed by laboratory testing of tissue or cells) that has spread locally or to other parts of the body, and standard treatments have not worked, you cannot tolerate them, or no standard treatment exists for your condition
- You have at least one tumor that can be measured using standard imaging guidelines
- You are reasonably able to carry out daily activities — your doctor rates your overall health and activity level as acceptable on a standard scale (confirm with trial site)
- Your doctor expects you to live for at least 3 more months
Who may not be able to join:
- Your cancer has actively spread to your brain or the membranes surrounding your brain and spinal cord
- You are still experiencing side effects from a previous cancer treatment that have not improved to a mild or near-normal level
- You have taken any other unapproved experimental drug or treatment within the 4 weeks before starting this trial
- You have had chemotherapy, radiation, biological therapy, hormone therapy, targeted therapy, immunotherapy, or other cancer treatments within the 4 weeks before starting this trial — though shorter waiting periods may apply for certain specific treatments (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 609-686-6502
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with Dose Limiting Toxicities as assessed by NCI CTCAE v5.0 (excluding cytokine release syndrome, CRS).; Number of participants with Tumor Response as assessed by RECIST version 1.1 criteria
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.